ChemoCentryx Inc (NASDAQ:CCXI)

During the Trading Day
7.45 +0.22 / +3.04%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.45 0.00 / 0.00%
 
Volume: 3.3K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$314.8M

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. It was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:

Employees

Shareholders

Individual stakeholders48.42%
Other institutional36.47%
Mutual fund holders25.44%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
Susan M. KanayaCFO, Secretary & Head-Investor Relations
Petrus BekkerChief Medical Officer
Juan C. JaenChief Scientific Officer & SVP-Drug Discovery
Anne-Marie S. DuliegeChief Strategic Development Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account